KISS FOR ORGANIZATIONS
KISS works with clinics, community organizations, universities, and public-health partners to design privacy-first pilots around sexual-health engagement, education, testing support, and partner communication.
Where program rules allow, existing public-health or foundation funding may be able to support technology, implementation, outreach, and evaluation.
A DIFFERENT FUNDING MODEL
KISS is a for-profit health-technology company, so many public-health grants are not direct startup grants. The opportunity is different: an eligible clinic, nonprofit, health department, university, or community organization may be able to include KISS as a technology, outreach, implementation, or evaluation expense when the funding source and award rules permit it.
The eligible organization applies for or uses an existing award aligned with HIV/STI prevention, testing, engagement, education, or linkage to care.
Where allowable, KISS can be budgeted as part of program delivery, technology, outreach, or evaluation.
The pilot uses a predefined measurement plan so both KISS and the partner learn what changed—and whether the model should scale.
POTENTIAL FUNDING PATHWAYS
Depending on the organization, geography, award, and program design, potential pathways can include federal, state, local, and private funding focused on HIV/STI prevention and sexual health.
Potential fit through eligible recipients or subrecipients when KISS-supported activities are allowable under the specific award and service model.
Potential fit for health departments and funded partners testing ways to improve prevention, partner notification, screening, engagement, and linkage.
Potential fit where digital engagement supports confidential sexual-health education, testing, referrals, or continuity of care.
Potential fit for nonprofit and community partners pursuing HIV prevention, LGBTQ+ health, health equity, outreach, and digital innovation funding.
A BETA THAT PRODUCES EVIDENCE
A strong beta is not simply a request to display flyers or generate downloads. KISS works best when the partner and KISS define a cohort, workflow, measurement period, and decision the pilot is meant to inform.
Example: 250–500 eligible patients, students, or community members offered KISS over a defined enrollment period.
Measure offer-to-download and download-to-activation, then identify where people drop out.
Track agreed behaviors such as encounter logging, reminders, repeat use, and partner-notification activity.
Where measurable and appropriate, evaluate referrals, testing follow-through, care navigation, or other partner-defined outcomes.
WHAT A PARTNER RECEIVES
Defined audience, workflow, timeline, responsibilities, success measures, and implementation assumptions.
Partner-ready implementation materials, onboarding guidance, and community-facing education.
Agreed metrics and reporting structure designed around program goals while protecting individual privacy.
When appropriate, KISS can provide product language, budget context, implementation details, and outcome measures for a partner’s application.
Pilot design can incorporate medical-advisor review and feedback from the communities and organizations the program is intended to serve.
At the end of the beta, both sides should have enough evidence to refine, expand, pause, or redesign the program.
RESPONSIBLE BY DESIGN
KISS does not guarantee grant eligibility, reimbursement, or allowability. Each funder and award has its own rules, and the recipient organization is responsible for confirming that proposed KISS costs and activities are permitted. KISS can provide the product, implementation, privacy, security, and measurement information a partner needs to make that determination.
Our goal is simple: build a pilot that is medically responsible, operationally realistic, measurable, and useful to the community it serves.
START A CONVERSATION
Tell us about your organization, community, funding source, or pilot idea. We’ll help determine whether there is a sensible path to test KISS—and what evidence the beta should produce.